過敏性氣喘治療藥市場:各藥物類型,各給藥途徑,各地區-2023年~2030年的市場規模,佔有率,展望,機會分析
市場調查報告書
商品編碼
1330271

過敏性氣喘治療藥市場:各藥物類型,各給藥途徑,各地區-2023年~2030年的市場規模,佔有率,展望,機會分析

Allergic Asthma Therapeutics Market, By Drug Type, By Route of Administration, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 220 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

過敏性氣喘,也稱為過敏性氣喘,是一種慢性發炎性疾病。過敏性氣喘是一種呼吸道疾病,當吸入過敏原時,呼吸的呼吸道會變窄。過敏性氣喘是指某人吸入過敏原後出現呼吸困難。當過敏反應促使氣道腫脹時就會發生這種情況。常見的過敏原包括花粉、皮屑和黴菌孢子。這種類型的氣喘在兒童和成人中很常見。過敏性氣喘的症狀包括呼吸急促、咳嗽、喘息、鼻塞、眼睛發癢和皮疹。氣喘是一種長期發炎性肺部疾病,由環境和遺傳影響促使的發炎和氣道狹窄引起。空氣污染、氣溶膠清潔產品、香菸煙霧、木材火災和強烈氣味等刺激性物質不會引起過敏反應。然而,它會刺激氣道並加重氣喘症狀。氣喘發作的特徵是氣道周圍的肌肉收緊(支氣管收縮),氣道變窄,促使呼吸困難。呼吸系統疾病盛行率的上升和主要參與者的策略擴張預計將在預測期內推動全球過敏性氣喘藥物市場的成長。

市場動態

呼吸系統疾病盛行率的增加和對具有成本效益的治療的需求不斷增長預計將在預測期內推動全球過敏性氣喘藥物市場的成長。此外,污染水平上升和慢性阻塞性肺病(COPD)病例迅速增加也是推動市場成長的因素。例如,2023年3月16日,根據世界衛生組織(WHO)的數據,慢性阻塞性肺病(COPD)是全球第三大死因,2020年促使323萬人死亡。

本調查的主要特徵

  • 本報告提供以2022年為基準年的預測期間(2023-2030 年)之全球過敏性氣喘治療藥市場的市場規模和復合年增長率(CAGR %)相關的詳區隔析。
  • 並闡明不同部門市場的潛在收入機會,說明該市場具有魅力的投資主張矩陣。
  • 同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
  • 並基於企業亮點,各類型投資組合、主要焦點、財務業績和市場策略等參數,介紹全球過敏性氣喘治療藥市場的主要參與者之企業簡介。
  • 藉由該報告提供的洞察,將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
  • 全球過敏性氣喘治療藥市場報告配合該行業的各種利益相關者,包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
  • 利益相關者可以透過全球過敏性氣喘治療藥市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

目錄

第1章 調查目的與前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場概況

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場魅力分析
    • 市場機會
    • 合併,收購,聯盟
    • 與資金籌措投資
    • 未來展望
    • 法規指南和遵守
    • 主要的發展
    • PEST分析
    • 波特五力分析

第4章 全球過敏性氣喘治療藥市場-COVID-19影響分析

  • 經濟影響
  • COVID-19流行病學
  • 供需的影響

第5章 過敏性氣喘治療藥的全球市場:各藥物類型,2018年-2030年

  • 皮質類固醇藥
  • 支氣管擴張藥
  • 白三烯調節藥
  • 免疫療法
  • 生技藥品
  • 其他

第6章 過敏性氣喘治療藥的全球市場:各給藥途徑,2018-2030年

  • 口服
  • 吸入
  • 其他

第7章 過敏性氣喘治療藥的全球市場:各地區,2018年~2030年

  • 北美
  • 美國
  • 加拿大
  • 南美
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他南美國家
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 中東
  • GCC
  • 以色列
  • 其他中東
  • 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情形

  • ASLAN Pharmaceuticals
  • Takeda Pharmaceutical Company Limited
  • CHIESI Farmaceutici S.p.A.
  • CSL
  • NIOX
  • Fountain Therapeutics
  • Eli Lilly and Company
  • GSK plc.
  • Infinity Pharmaceuticals, Inc.
  • Mabtech
  • Kineta Inc.
  • Marinomed Biotech AG
  • Mycenax Biotech Inc.
  • AstraZeneca
  • Panacea Biotec

第9章 章節

  • 調查手法
  • 關於出版社
簡介目錄
Product Code: CMI4019

Allergic asthma, also known as allergy-induced asthma, is a chronic inflammatory condition Allergic asthma is a breathing condition where the airways you breathe through tighten when someone inhale an allergen. Allergic asthma is when someone develop breathing difficulties from inhaling allergens. It occurs when the airways swell as part of an allergic reaction. Common allergens include pollen, dander and mold spores. This type of asthma is very common in both children and adults. Symptoms of allergic asthma can include shortness of breath, coughing, wheezing, stuffy nose, itchy eyes and a rash. Asthma is a long-term inflammatory lung disease which is caused by inflammation and narrowing in the air passage resulting from environmental and genetic influences. Irritants such as air pollution, aerosol cleaning products, tobacco smoke, wood fires, and strong odors don't cause an allergic reaction. But they may inflame your airways and make asthma symptoms worse. An asthma attack is characterized by tightening of the muscles around the airways (bronchoconstriction), which narrows the airway and makes breathing difficult. The rising incidence of respiratory diseases and the strategic expansions by the key players are expected to propel the growth of global allergic asthma therapeutics market over the forecast period.

Market Dynamics

The rising incidence of respiratory diseases and the growing demand for cost-effective treatments are expected to propel the global allergic asthma therapeutics market growth over the forecast period. Additionally, an increase in pollution levels and an upsurge in cases of chronic obstructive pulmonary diseases (COPD) are other factors boosting the market growth. For instance, on March 16, 2023, according to the World Health Organization (WHO), Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global allergic asthma therapeutics market, and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global allergic asthma therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are ASLAN Pharmaceuticals, Takeda Pharmaceutical Company Limited, CHIESI Farmaceutici S.p.A., CSL, NIOX, Fountain Therapeutics, Eli Lilly and Company, GSK plc., Infinity Pharmaceuticals, Inc., Mabtech, Kineta Inc., Marinomed Biotech AG, Mycenax Biotech Inc., AstraZeneca, and Panacea Biotec.
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global allergic asthma therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global allergic asthma therapeutics market

Detailed Segmentation:

  • Global Allergic Asthma Therapeutics Market, By Drug Type:
    • Corticosteroids
    • Bronchodilators
    • Leukotriene modifiers
    • Immunotherapy
    • Biologics
    • Others
  • Global Allergic Asthma Therapeutics Market By Route of Administration:
    • Oral
    • Inhaled
    • Others
  • Global Allergic Asthma Therapeutics Market, By Region:
    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • ASLAN Pharmaceuticals
    • Takeda Pharmaceutical Company Limited
    • CHIESI Farmaceutici S.p.A.
    • CSL
    • NIOX
    • Fountain Therapeutics
    • Eli Lilly and Company
    • GSK plc.
    • Infinity Pharmaceuticals, Inc.
    • Mabtech
    • Kineta Inc.
    • Marinomed Biotech AG
    • Mycenax Biotech, Inc.
    • AstraZeneca
    • Panacea Biotec

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
    • Merger, Acquisition, Collaborations
    • Funding and Investment
    • Future Prospective
    • Regulatory Guideline and Compliances
    • Key Developments
    • PEST Analysis
    • PORTER's Analysis

4. Global Allergic Asthma Therapeutics Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Allergic Asthma Therapeutics Market, By Drug Type, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segment Trends
  • Corticosteroids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Bronchodilators
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Leukotriene modifiers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Immunotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Biologics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Allergic Asthma Therapeutics Market, By Route of Administration, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018-2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Inhaled
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Allergic Asthma Therapeutics Market, By Region, 2018-2030, (US$ Billion)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Billion)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • ASLAN Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Takeda Pharmaceutical Company Limited
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CHIESI Farmaceutici S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • CSL
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • NIOX
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fountain Therapeutics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GSK plc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Infinity Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mabtech
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kineta Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Marinomed Biotech AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Mycenax Biotech Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Panacea Biotec
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us